本頁面由Tiger Trade Technology Pte. Ltd.提供服務

和黃醫藥

12.24
+0.06000.49%
成交量:4.14萬
成交額:50.71萬
市值:21.35億
市盈率:121.25
高:12.29
開:12.18
低:12.16
收:12.18
52周最高:18.30
52周最低:9.77
股本:1.74億
流通股本:1.04億
量比:0.68
換手率:0.04%
股息:- -
股息率:- -
每股收益(TTM):0.1010
每股收益(LYR):2.60
淨資產收益率:1.46%
總資產收益率:-1.24%
市淨率:1.69
市盈率(LYR):4.71

資料載入中...

2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/01/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]